Yes, Our March 23, 2021 response letter impreci
Post# of 148293
(Total Views: 497)
Posted On: 07/08/2021 1:14:13 PM
Yes,
We have the data, it was just the analysis that wasn't up to standards, apparently.
I'm not sure exactly what they mean by revalidation and additional analysis of existing data, but am very glad we have all the data we need.
I like Bruce Patterson a lot, as he is very knowledgeable, but it sure seems like he was a big part of the RTF and thus our lack of income from HIV combo therapy. Amarex also seems to have done a poor job with the BLA. IMO CYDY should have prioritized this BLA refiling work, but am very glad to see Recknor seems to have gotten things back on track. Not sure why Mahboob couldn't get the job done.
CYDY has a good history (although we only have heard their side of the story thus far) of cutting ties with underperformers (Patterson - RO test, Mahboob - BLA resubmission, Amarex - muffed BLA filing, Pestell - ?? not sure what happened there), and I'm fine with that.
Just get the BLA done. It seems like we are on track.
Stock price way down, but there is pretty good progress behind the scenes.
Really is no need to change coaches for our team now.
Quote:
Our March 23, 2021 response letter imprecisely described the receptor occupancy analysis as “current scientific work being performed…” More precisely, the work involves revalidation of previously performed analyses from already available data. This revalidation is now being performed by a leading global healthcare diagnostics company pursuant to cGLP standards.
We have the data, it was just the analysis that wasn't up to standards, apparently.
I'm not sure exactly what they mean by revalidation and additional analysis of existing data, but am very glad we have all the data we need.
I like Bruce Patterson a lot, as he is very knowledgeable, but it sure seems like he was a big part of the RTF and thus our lack of income from HIV combo therapy. Amarex also seems to have done a poor job with the BLA. IMO CYDY should have prioritized this BLA refiling work, but am very glad to see Recknor seems to have gotten things back on track. Not sure why Mahboob couldn't get the job done.
CYDY has a good history (although we only have heard their side of the story thus far) of cutting ties with underperformers (Patterson - RO test, Mahboob - BLA resubmission, Amarex - muffed BLA filing, Pestell - ?? not sure what happened there), and I'm fine with that.
Just get the BLA done. It seems like we are on track.
Stock price way down, but there is pretty good progress behind the scenes.
Really is no need to change coaches for our team now.
(11)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼